| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/03/2013 | WO2013003498A2 Acoustic cytometry methods and protocols |
| 01/03/2013 | WO2013003429A1 End-tidal gas monitoring apparatus |
| 01/03/2013 | WO2013003384A1 Signatures and determinants associated with prostate cancer progression and methods of use thereof |
| 01/03/2013 | WO2013003112A1 Methods and compositions for treatment of cancer and autoimmune disease |
| 01/03/2013 | WO2013002894A1 Indicator device |
| 01/03/2013 | WO2013002858A1 Nanoreactor printing |
| 01/03/2013 | WO2013002752A1 Method of operating a catalytic steam-hydrocarbon reformer |
| 01/03/2013 | WO2013002731A1 Foetal nucleated red blood cell detection |
| 01/03/2013 | WO2013002723A1 Method for specific identification of target biomolecules |
| 01/03/2013 | WO2013002721A1 Cell binding assay |
| 01/03/2013 | WO2013002718A1 Method of determining active concentration |
| 01/03/2013 | WO2013002717A1 Method of determining active concentration by calibration-free analysis |
| 01/03/2013 | WO2013002713A1 Device and method for indication of sulphur content in a fuel |
| 01/03/2013 | WO2013002631A1 New flow cytometric method for detection of circulating endothelial cells |
| 01/03/2013 | WO2013002455A1 Standard marker for distinguishing country of origin or age of processed ginseng, establishing method thereof, or method for distinguishing country of origin or age of ginseng using same |
| 01/03/2013 | WO2013002435A1 System for treating sewage/waste water and method for treating sewage/waste water based on pre-predictive control |
| 01/03/2013 | WO2013002434A1 Marker containing hpαr as active ingredient for diagnosing lung cancer |
| 01/03/2013 | WO2013002433A1 Method for diagnosing breast cancer |
| 01/03/2013 | WO2013002422A1 Method for diagnosing type of pancreatic tumor |
| 01/03/2013 | WO2013002419A1 Mitochondrial disease-specific induced pluripotent stem cells, method of producing same and use thereof |
| 01/03/2013 | WO2013002404A1 Method for alleviating fear memory |
| 01/03/2013 | WO2013002403A1 Conjugate for use in immunoassay method |
| 01/03/2013 | WO2013002381A1 Method for evaluating fatty liver disease, device for evaluating fatty liver disease, method for evaluating fatty liver disease, program for evaluating fatty liver disease, system for evaluating fatty liver disease, information-communication terminal device, and method for searching for substance used to prevent or improve fatty-liver-disease |
| 01/03/2013 | WO2013002377A1 Blood-sugar measurement device and blood-sugar measurement method |
| 01/03/2013 | WO2013002309A1 Non-specific reaction inhibitor, and method and kit for inhibiting non-specific reaction |
| 01/03/2013 | WO2013002193A1 Sensor chip for use in measuring intermolecular interactions, having been subjected to nonspecific-adsorption inhibition treatment using surfactant, process for producing said sensor chip, and method for measuring intermolecular interactions using said sensor chip |
| 01/03/2013 | WO2013002086A1 Receptor gene for peptide cancer antigen-specific t cell |
| 01/03/2013 | WO2013001955A1 Optical film thickness measurement method, optical film thickness measurement system, optical film thickness measurement program, and so on |
| 01/03/2013 | WO2013001895A1 Carrier for material immobilization for use in immunoassay |
| 01/03/2013 | WO2013001894A1 Base material having hydrophilic layer |
| 01/03/2013 | WO2013001663A1 Device for evaluating catalytic performance in purifying exhaust gas |
| 01/03/2013 | WO2013001507A2 Treatment planning based on polypeptide radiotoxicity serum markers |
| 01/03/2013 | WO2013001461A1 Preparation of reaction chambers with dried proteins |
| 01/03/2013 | WO2013001447A1 Molecular architecture on magnetic particles for affinity assays with low non-specific binding |
| 01/03/2013 | WO2013001431A1 Multiple examinations of a sample |
| 01/03/2013 | WO2013001400A1 Detection of clusters of magnetic particles |
| 01/03/2013 | WO2013001383A1 Means for the examination of body fluids |
| 01/03/2013 | WO2013001293A2 Diagnostic method |
| 01/03/2013 | WO2013001232A1 In vitro method using human skin for evaluating the influence of abc transporters |
| 01/03/2013 | WO2013001102A1 System for detecting commonly abused drugs |
| 01/03/2013 | WO2013001101A1 Method and system for providing an assembly of an amount of used plastic material and an information carrier carrying quality data of the amount |
| 01/03/2013 | WO2013001007A1 An improved micropatch for assessing chemical contact allergy |
| 01/03/2013 | WO2013000982A1 Method for screening cells |
| 01/03/2013 | WO2013000930A1 Epcam detection |
| 01/03/2013 | WO2013000920A2 Methods for treating and/or limiting development of diabetes |
| 01/03/2013 | WO2013000853A1 Method and apparatus for magnetic flow cytometry |
| 01/03/2013 | WO2013000568A1 Method of obtaining a binder to prepro-vasopressin or fragments thereof |
| 01/03/2013 | WO2013000246A1 Hepatic fibrosis detection apparatus and system |
| 01/03/2013 | WO2013000086A1 Selective glycosidase inhibitors and uses thereof |
| 01/03/2013 | WO2013000085A1 Selective glycosidase inhibitors and uses thereof |
| 01/03/2013 | WO2013000084A1 Selective glycosidase inhibitors and uses thereof |
| 01/03/2013 | WO2013000064A1 Alternative splicing modulators and splice variants and their use in the control and detection of pluripotency and differentiation |
| 01/03/2013 | WO2013000021A1 A cell mediated immune response assay with enhanced sensitivity |
| 01/03/2013 | WO2012155097A3 Systems and methods for producing an evaporation barrier in a reaction chamber |
| 01/03/2013 | WO2012145299A3 Devices and methods for determination of bioavailability of pollutants |
| 01/03/2013 | WO2012142542A3 New ribosomal targets for antibiotic drug discovery |
| 01/03/2013 | WO2012139047A3 Identifying and enumerating early granulated cells (egcs) |
| 01/03/2013 | WO2012135024A3 Sensor mounting into the temperature well of a transformer |
| 01/03/2013 | WO2012134195A3 Detection of target nucleic acid sequence by pto cleavage and extension-dependent cleavage |
| 01/03/2013 | WO2012131380A3 Cancer detection |
| 01/03/2013 | WO2012129444A3 Rapid tests for the detection of inhibitors of enzymes and human exposure to the same |
| 01/03/2013 | WO2012129048A3 Methods to predict sperm retrieval in males |
| 01/03/2013 | WO2012127429A3 Systems for custom coloration |
| 01/03/2013 | WO2012122379A9 Microfluidic cytochemical staining system |
| 01/03/2013 | WO2012122371A3 Radial flow immunoassay and methods of production and use thereof |
| 01/03/2013 | WO2012118863A9 Therapies that target autoimmunity for treating glaucoma and optic neuropathy |
| 01/03/2013 | WO2012113907A3 Paper support and method of recovering biological material therefrom |
| 01/03/2013 | WO2012104624A3 Biomarkers for osteoarthritis |
| 01/03/2013 | WO2012101599A3 Glycogen synthase kinase-3 inhibitors |
| 01/03/2013 | WO2012088054A3 Detection of an analyte in a sample |
| 01/03/2013 | WO2012087913A3 Peptide reagents and methods for detection of colon dysplasia |
| 01/03/2013 | WO2012085555A3 Biomarkers for diagnosing schizophrenia |
| 01/03/2013 | WO2012003348A3 Apparatus for disease detection |
| 01/03/2013 | WO2011161438A3 Biomarkers for autism spectrum conditions, in particular asperger syndrome |
| 01/03/2013 | WO2009101538A3 Quality control for bilirubinometers |
| 01/03/2013 | US20130007913 Biological systems input-output response system and plant sentinels |
| 01/03/2013 | US20130007910 Structure of the brassinosteroid receptor bri1, and modulation of bri1 signaling |
| 01/03/2013 | US20130007903 Efficient haploid cell sorting flow cytometer systems |
| 01/03/2013 | US20130006047 Method for identifying a mammal receptive to embryo transfer |
| 01/03/2013 | US20130005836 Composition and methods related to s100 a2 |
| 01/03/2013 | US20130005802 Treatment of wnt/frizzled-related diseases |
| 01/03/2013 | US20130005782 Method for integrin ligand discovery |
| 01/03/2013 | US20130005668 Nucleic acids and corresponding proteins entitled 158p3d2 useful in treatment and detection of cancer |
| 01/03/2013 | US20130005611 Arrays Of Biological Membranes And Methods And Use Thereof |
| 01/03/2013 | US20130005608 Yeast screens for treatment of human disease |
| 01/03/2013 | US20130005601 Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| 01/03/2013 | US20130005599 Methods and systems of using exosomes for determining phenotypes |
| 01/03/2013 | US20130005598 Methods for Diagnosing The Malignant Potential of Pancreatic Cystic Lesions |
| 01/03/2013 | US20130005592 Methods and compositions for predicting cancer therapy response |
| 01/03/2013 | US20130005588 Method for determining substance non-toxicity |
| 01/03/2013 | US20130005049 Devices and methods for detecting single nucleotide polymorphisms |
| 01/03/2013 | US20130004978 Anti-lg3 antibodies and uses thereof |
| 01/03/2013 | US20130004977 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays |
| 01/03/2013 | US20130004976 Human insulin assay and assay reagent |
| 01/03/2013 | US20130004975 Method of Stabilizing Heme Protein and Storage Solution Therefor |
| 01/03/2013 | US20130004974 Extracellular and membrane-associated prostate cancer markers |
| 01/03/2013 | US20130004973 METHODS OF USE FOR AN IMMUNOASSAY DETECTING FRAGMENT Ba |
| 01/03/2013 | US20130004972 Method for the detection of prediabetes |
| 01/03/2013 | US20130004971 CYSTATIN C, beta2 MICROGLOBULIN, alpha1 MICROGLOBULIN AND GENES FOR SAME, ANTIBODY, AND KIT AND METHOD FOR DIAGNOSIS OF FELINE NEPHROPATHY |
| 01/03/2013 | US20130004970 Methods for prediction of clinical outcome to epidermal growth factor receptor inhibitors by cancer patients |